Litigation Details for Novartis Pharmaceuticals Corporation v. MSN Pharmaceuticals Inc. (D. Del. 2024)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. MSN Pharmaceuticals Inc. (D. Del. 2024)
| Docket | ⤷ Sign Up | Date Filed | 2024-10-24 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | |
| Jury Demand | None | Referred To | |
| Patents | 8,962,630; 9,416,136 | ||
| Link to Docket | External link to docket | ||
Details for Novartis Pharmaceuticals Corporation v. MSN Pharmaceuticals Inc. (D. Del. 2024)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2024-10-24 | 1 | Complaint | expiration of U.S. Patent Nos. 8,962,630 (“the ’630 patent”) and 9,416,136 (“the ’136 patent”) (collectively…. This is an action for patent infringement arising under the patent laws of the United States, … prior to the expiration of the ’630 patent and the ’136 patent, and (ii) that ANDA No. 215976 includes…355(j)(2)(A)(vii)(IV) against the ’630 patent and the ’136 patent. 10. Defendants have committed…district prior to the expiration of the ’630 patent and the ’136 patent, an act of infringement that has led | External link to document |
| 2024-10-24 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,962,630; 9,416,136. (oam) (… 24 October 2024 1:24-cv-01193 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
